Qureator is excited to announce its upcoming presentation at the WuXi AppTec Japan webinar on March 12, 2025. The session will spotlight Qureator’s vascularized Tumor Immune Microenvironment (vTIME) model, a next-generation platform designed to advance immunotherapy development. Qureator’s leadership will highlight recent progress from key collaborations with pharmaceutical and biotech partners, demonstrating how its physiologically relevant, AI-integrated models are accelerating the path from discovery to clinic. The webinar marks an important opportunity to share cutting-edge innovations in reshaping the tumor microenvironment and enabling more predictive immuno-oncology strategies.